Literature DB >> 12107115

Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.

Cassian Sitaru1, Arno Kromminga, Takashi Hashimoto, Eva B Bröcker, Detlef Zillikens.   

Abstract

Epidermolysis bullosa acquisita is an autoimmune subepidermal blistering disease associated with autoantibodies to type VII collagen, the major constituent of anchoring fibrils. Previous attempts to demonstrate the blister-inducing potential of autoantibodies to this protein have failed. To address this question, we used an in vitro model involving cryosections of human skin incubated with patients' autoantibodies and leukocytes from healthy donors. We show that sera from 14 of 16 epidermolysis bullosa acquisita patients, in contrast to sera from healthy controls, induced dermal-epidermal separation in the cryosections. Recruitment and activation of neutrophils at the dermal-epidermal junction was necessary for split induction, whereas mononuclear cells were not required. Importantly, patients' autoantibodies affinity-purified against a recombinant form of the noncollagenous 1 domain of type VII collagen retained their blister-inducing capacity in a dose-dependent manner, whereas patients' IgG that was depleted of reactivity to type VII collagen lost this ability. Monoclonal antibody LH7.2 to the noncollagenous 1 domain of type VII collagen also induced subepidermal splits in the cryosections; F(ab')(2) fragments of autoantibodies to type VII collagen were not pathogenic. We demonstrate the capacity of autoantibodies to type VII collagen to trigger an Fcgamma-dependent inflammation leading to split formation in cryosections of human skin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107115      PMCID: PMC1850704          DOI: 10.1016/s0002-9440(10)64182-x

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.

Authors:  D Zillikens; K Herzele; M Georgi; E Schmidt; I Chimanovitch; H Schumann; J M Mascaro; L A Diaz; L Bruckner-Tuderman; E B Bröcker; G J Giudice
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies.

Authors:  M Chen; D R Keene; F K Costa; S H Tahk; D T Woodley
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

3.  Most anchoring fibrils in human skin originate and terminate in the lamina densa.

Authors:  H Shimizu; A Ishiko; T Masunaga; Y Kurihara; M Sato; L Bruckner-Tuderman; T Nishikawa
Journal:  Lab Invest       Date:  1997-06       Impact factor: 5.662

4.  Anchoring of basal lamina to elastic fibers by elastic fibrils.

Authors:  T Kobayasi
Journal:  J Invest Dermatol       Date:  1977-06       Impact factor: 8.551

5.  Herpes gestationis. Immunopathology and characterization of the HG factor.

Authors:  S I Katz; K C Hertz; H Yaoita
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

6.  Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.

Authors:  W R Gammon; D M Lewis; J R Carlo; W M Sams; C E Wheeler
Journal:  J Invest Dermatol       Date:  1980-10       Impact factor: 8.551

7.  Epidermolysis bullosa acquisita: ultrastructural and immunological studies.

Authors:  H Yaoita; R A Briggaman; T J Lawley; T T Provost; S I Katz
Journal:  J Invest Dermatol       Date:  1981-04       Impact factor: 8.551

8.  Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.

Authors:  A Kromminga; C Scheckenbach; M Georgi; C Hagel; R Arndt; E Christophers; E B Bröcker; D Zillikens
Journal:  J Autoimmun       Date:  2000-11       Impact factor: 7.094

9.  The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid.

Authors:  R Y Chan; K Bhol; N Tesavibul; E Letko; R K Simmons; C S Foster; A R Ahmed
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

10.  Differential regulation of beta1 integrins by chemoattractants regulates neutrophil migration through fibrin.

Authors:  J D Loike; L Cao; S Budhu; E E Marcantonio; J El Khoury; S Hoffman; T A Yednock; S C Silverstein
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

View more
  34 in total

Review 1.  Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.

Authors:  Mei Chen; Gene H Kim; Lori Prakash; David T Woodley
Journal:  Autoimmunity       Date:  2011-09-28       Impact factor: 2.815

Review 2.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

3.  Granulocyte-dependent autoantibody-induced skin blistering.

Authors:  Kinga Csorba; Sebastian Sitaru; Cassian Sitaru
Journal:  J Vis Exp       Date:  2012-10-12       Impact factor: 1.355

4.  Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.

Authors:  Kelly N Messingham; Jeffrey W Wang; Heather M Holahan; Rupasree Srikantha; Samantha C Aust; Janet A Fairley
Journal:  Exp Dermatol       Date:  2015-11-23       Impact factor: 3.960

5.  The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies.

Authors:  Peter Jandus; Kayluz Frias Boligan; David F Smith; Elisabeth de Graauw; Bodo Grimbacher; Camilla Jandus; Mai M Abdelhafez; Alain Despont; Nicolai Bovin; Dagmar Simon; Robert Rieben; Hans-Uwe Simon; Richard D Cummings; Stephan von Gunten
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

Review 6.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

7.  Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.

Authors:  Artem Vorobyev; Hideyuki Ujiie; Andreas Recke; Jacqueline J A Buijsrogge; Marcel F Jonkman; Hendri H Pas; Hiroaki Iwata; Takashi Hashimoto; Soo-Chan Kim; Jong Hoon Kim; Richard Groves; Unni Samavedam; Yask Gupta; Enno Schmidt; Detlef Zillikens; Hiroshi Shimizu; Ralf J Ludwig
Journal:  J Invest Dermatol       Date:  2015-02-17       Impact factor: 8.551

8.  Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

Authors:  Cassian Sitaru; Sidonia Mihai; Christoph Otto; Mircea T Chiriac; Ingrid Hausser; Barbara Dotterweich; Hitoshi Saito; Christian Rose; Akira Ishiko; Detlef Zillikens
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

9.  Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.

Authors:  Kinga Csorba; Alina Sesarman; Eva Oswald; Vasile Feldrihan; Anja Fritsch; Takashi Hashimoto; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

10.  Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita.

Authors:  Alina Sesarman; Ana Gabriela Sitaru; Florina Olaru; Detlef Zillikens; Cassian Sitaru
Journal:  J Mol Med (Berl)       Date:  2008-06-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.